Payal Rabde, a Healthcare Industry Expert, highlights that the clostridium diagnostics market has reached USD 4.38 billion in 2026 and is on track to reach USD 8.60 billion by 2035, advancing at a CAGR of 7.80%. Key clostridium diagnostics market companies shaping the market include Cepheid, BD, bioMérieux, Abbott Agilent Technologies while major growth segments span species, technology, product type, end user, region.